TA-1801
TA-1801 is a hypolipidemic agent, the active form is TA-1901A[1][2].
Product Specifications
CAS Number
[88352-44-7]
UNSPSC
12352005
Target
Drug Intermediate
Type
Reference compound
Related Pathways
Others
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/TA-1801.html
Solubility
10 mM in DMSO
Smiles
O=C(OCC)CC1=C(C2=CC=CO2)OC(C3=CC=C(Cl)C=C3)=N1
Molecular Formula
C17H14ClNO4
Molecular Weight
331.75
References & Citations
[1]Moriya T, et al. Synthesis of ethyl 2- (4-chlorophenyl) -5- (2-furyl) -4-oxazoleacetate, a hypolipidemic agent, and related compounds. J Med Chem. 1988 Jun;31 (6) :1197-204.|[2]Kaji H, et al. Glucuronidation of 2- (4-chlorophenyl) -5- (2-furyl) -4-oxazoleacetic acid (TA-1801A) in humans: species differences in liver and intestinal microsomes. Drug Metab Pharmacokinet. 2005 Jun;20 (3) :206-11.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6190349-01 0.1 mL
Glutamic Pyruvic Transaminase (GPT, Glutamic-pyruvic Transaminase 1, Glutamate Pyruvate Transaminase 1, GPT 1, GPT1, Alanine Aminotransferase 1, AAT1, ALT1, Glutamic-alanine Transaminase 1) (MaxLight 405)
Ask
View Details MBS6190349-02 5x 0.1 mL
Glutamic Pyruvic Transaminase (GPT, Glutamic-pyruvic Transaminase 1, Glutamate Pyruvate Transaminase 1, GPT 1, GPT1, Alanine Aminotransferase 1, AAT1, ALT1, Glutamic-alanine Transaminase 1) (MaxLight 405)
Ask
View Details